Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea

被引：0
|
作者：
Hyeon-Jeong Lee
Songhee Cho
Jungeun Park
Yan Jin
Hyung Min Kim
Donghyun Jee
机构：
[1] National Evidence-based Healthcare Collaborating Agency,Division of Healthcare Technology Assessment Research
[2] National Evidence-based Healthcare Collaborating Agency,Patient
[3] Nanjing University of Chinese Medicine,Centered Clinical Research Coordinating Center
[4] Kai Health,Department of Rehabilitation, College of Acupuncture and Moxibustion and Massage Health Preservation and Rehabilitation
[5] St. Vincent’s Hospital,Artificial intelligence
[6] The College of Medicine,Department of Ophthalmology and Visual Science
[7] Catholic University of Korea,undefined
来源：
BMC Health Services Research | / 23卷
关键词：
Anti-VEGF injection; Cost-effectiveness analysis; Panretinal Photocoagulation; Proliferative diabetic retinopathy; South Korea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Management of Diabetic Retinopathy in the Anti-Vascular Endothelial Growth Factor Era
    Carroll, Robert M.
    Bracha, Peter
    Miller, Charles G.
    Brucker, Alexander J.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (03): : 461 - 463
  • [42] Intravitreal Ranibizumab Combined with Panretinal Photocoagulation in Patients with Treatment-Naive Proliferative Diabetic Retinopathy
    Ferraz, Daniel
    Sophie, Raafay
    Bittencourt, Millena
    Preti, Rony
    Vazquez, Lisa
    Motta, Augusto
    Hanout, Mostafa
    Sepah, Yasir
    Quan Dong Nguyen
    Takahashi, Walter
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [43] Subconjunctival hemorrhage after intravitreal injection of anti-vascular endothelial growth factor
    Cheolmin Yun
    Jaeryung Oh
    Soon-Young Hwang
    Seong-Woo Kim
    Kuhl Huh
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1465 - 1470
  • [44] Endophthalmitis following intravitreal injection of anti-vascular endothelial growth factor agents
    Storey, Philip P.
    Patel, Dillan
    Garg, Sunir
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2020, 55 (04): : 286 - 292
  • [45] Beyond Intravitreal Injection of Anti-Vascular Endothelial Growth Factor (VEGF) Therapy
    d'Amico, G.
    Caporossi, T.
    Pagliara, M. M.
    Molle, F.
    Lepore, D.
    Focosi, F.
    Balestrazzi, E.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [46] Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy
    Alsoudi, Amer F.
    Wai, Karen M.
    Koo, Euna
    Parikh, Ravi
    Mruthyunjaya, Prithvi
    Rahimy, Ehsan
    JAMA OPHTHALMOLOGY, 2024, 142 (10) : 972 - 975
  • [47] Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
    Dervenis, Panagiotis
    Dervenis, Nikolaos
    Smith, Jonathan M.
    Steel, David H. W.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (05):
  • [48] Subconjunctival hemorrhage after intravitreal injection of anti-vascular endothelial growth factor
    Yun, Cheolmin
    Oh, Jaeryung
    Hwang, Soon-Young
    Kim, Seong-Woo
    Huh, Kuhl
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 253 (09) : 1465 - 1470
  • [49] Intravitreal Anti-vascular Endothelial Growth Factor Injection for Retinopathy of Prematurity: A Systematic Review and Meta-Analysis
    Taher, Nada O.
    Ghaddaf, Abdullah A.
    Al-Ghamdi, Sarah A.
    Homsi, Jumanah J.
    Al-Harbi, Bandar J.
    Alomari, Lugean K.
    Almarzouki, Hashem S.
    FRONTIERS IN MEDICINE, 2022, 9
  • [50] Transient regression of new vessels after anti-vascular endothelial growth factor monotherapy in proliferative diabetic retinopathy
    Venkatesh, Ramesh
    Anilkumar, Aaditi
    Mangla, Rubble
    Sharief, Shama
    Chhablani, Jay
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2024, 107 (05) : 587 - 588
12345